• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[横纹肌肉瘤预后因素分析。软组织肉瘤协作研究(CWS - 81)的初步单因素和多因素结果]

[Analysis of prognostic factors in rhabdomyosarcoma. Preliminary univariate and multivariate results of the Cooperative Soft Tissue Sarcoma Study (CWS-81)].

作者信息

Suder J, Stienen U, Kaatsch P, Harms D, Schmidt D, Spaar H J, Treuner J

出版信息

Klin Padiatr. 1986 May-Jun;198(3):218-23. doi: 10.1055/s-2008-1026880.

DOI:10.1055/s-2008-1026880
PMID:3523027
Abstract

The characteristics of 129 children with rhabdomyosarcoma entered into the CWS-81 study between 1981 and 1984 were examined for their relationship to prognosis. Prognosis was defined as relapse-free survival time. The trial was stratified to clinical groups depending on the surgical procedure at onset. So, each group had to be analysed separately. The patient characteristics of group I/IIA mostly related to prognosis were primary site (disease in extremities, unfavorable; paratesticular primary, favorable) and tumor infiltration into adjacent bone (bone infiltration, unfavorable). In group IIB/III the degree of tumor response within 7-9 weeks, chemotherapy exclusively given, was the only characteristic significantly related to prognosis (greater than 2/3 tumor reduction, favorable; less than 2/3 tumor reduction, unfavorable). Other prognostic factors as histological subtype, primary site, tumor diameter, lymph node involvement, bone infiltration, sex and age had no significant influence. The tumor diameter was the only characteristic with significant influence in group IV. The larger the tumor diameter, the poorer was prognosis. Furthermore, the alveolar subtype was seen predominantly in non-responding tumors of group IV. In group III, we fitted the patient characteristics in a multivariate regression model (Cox's model). The degree of tumor response within 7-9 weeks was analysed to be the main hazard function related to prognosis. In future, the degree of tumor response within a certain time can be used as the measurement of effectiveness of chemotherapy. So, in patients of group III and IV a risk adapted therapeutic procedure can be undertaken.

摘要

对1981年至1984年间纳入CWS - 81研究的129例横纹肌肉瘤患儿的特征进行了检查,以探讨其与预后的关系。预后定义为无复发生存时间。该试验根据发病时的手术程序分为不同临床组。因此,每组必须单独分析。I/IIA组中与预后最相关的患者特征是原发部位(四肢疾病,预后不良;睾丸旁原发,预后良好)和肿瘤浸润至相邻骨骼(骨浸润,预后不良)。在IIB/III组中,仅接受化疗7 - 9周内的肿瘤反应程度是唯一与预后显著相关的特征(肿瘤缩小超过2/3,预后良好;肿瘤缩小少于2/3,预后不良)。其他预后因素,如组织学亚型、原发部位、肿瘤直径、淋巴结受累、骨浸润、性别和年龄,均无显著影响。肿瘤直径是IV组中唯一有显著影响的特征。肿瘤直径越大,预后越差。此外,肺泡型主要见于IV组无反应的肿瘤中。在III组中,我们将患者特征纳入多元回归模型(Cox模型)。分析得出7 - 9周内的肿瘤反应程度是与预后相关的主要风险函数。未来,一定时间内的肿瘤反应程度可作为化疗疗效的衡量指标。因此,对于III组和IV组患者,可以采取风险适应性治疗方案。

相似文献

1
[Analysis of prognostic factors in rhabdomyosarcoma. Preliminary univariate and multivariate results of the Cooperative Soft Tissue Sarcoma Study (CWS-81)].[横纹肌肉瘤预后因素分析。软组织肉瘤协作研究(CWS - 81)的初步单因素和多因素结果]
Klin Padiatr. 1986 May-Jun;198(3):218-23. doi: 10.1055/s-2008-1026880.
2
[Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology].[儿童横纹肌肉瘤(RMS)的治疗结果。小儿肿瘤学会软组织肉瘤合作研究(CWS - 81)报告]
Klin Padiatr. 1986 May-Jun;198(3):208-17. doi: 10.1055/s-2008-1026879.
3
Prognostic factors in children with rhabdomyosarcoma.横纹肌肉瘤患儿的预后因素
Natl Cancer Inst Monogr. 1981 Apr(56):83-92.
4
Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.横纹肌肉瘤研究组III和IV中接受治疗的非转移性横纹肌肉瘤患者的预后因素分析:儿童肿瘤研究组
J Clin Oncol. 2006 Aug 20;24(24):3844-51. doi: 10.1200/JCO.2005.05.3801.
5
European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.欧洲关于儿童转移性横纹肌肉瘤的多中心研究(MMT4 - 89和MMT4 - 91):最终结果及预后因素分析
J Clin Oncol. 2004 Dec 1;22(23):4787-94. doi: 10.1200/JCO.2004.04.083.
6
Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?II组横纹肌肉瘤及横纹肌肉瘤样肿瘤:放疗是否必要?
J Clin Oncol. 2004 Jan 1;22(1):143-9. doi: 10.1200/JCO.2004.04.180.
7
[Treatment of soft tissue sarcomas in childhood and adolescence: results of the CWS-81 multicenter therapy study].[儿童及青少年软组织肉瘤的治疗:CWS - 81多中心治疗研究结果]
Klin Padiatr. 1991 Jul-Aug;203(4):211-9. doi: 10.1055/s-2007-1025432.
8
[Results of the treatment of non-rhabdomyosarcomatous soft tissue neoplasms within the scope of the CWS 81 study].[CWS 81研究范围内非横纹肌肉瘤性软组织肿瘤的治疗结果]
Klin Padiatr. 1987 May-Jun;199(3):209-17. doi: 10.1055/s-2008-1026792.
9
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.针对儿童、青少年和青年局部软组织肉瘤的CWS-91合作试验。
J Clin Oncol. 2009 Mar 20;27(9):1446-55. doi: 10.1200/JCO.2007.15.0466. Epub 2009 Feb 17.
10
[Improved local tumor control by early and risk-adjusted use of radiotherapy in primary non-resectable rhabdomyosarcomas: results of CWS 81 and 86 studies].[通过对原发性不可切除横纹肌肉瘤早期及风险调整放疗提高局部肿瘤控制率:CWS 81和86研究结果]
Klin Padiatr. 1994 Jul-Aug;206(4):269-76. doi: 10.1055/s-2008-1046613.

引用本文的文献

1
Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas.原发性不可切除横纹肌肉瘤中异环磷酰胺与环磷酰胺反应率的比较。
Cancer Chemother Pharmacol. 1989;24 Suppl 1:S48-50. doi: 10.1007/BF00253241.